Department of Dermatology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Beijing Key Laboratory for Genetics of Birth Defects; MOE Key Laboratory of Major Diseases in Children; Center for Medical Genetics, Beijing Pediatric Research Institute; Beijing Children's Hospital, Capital Medical University; National Center for Children's Health, Beijing, China.
Pigment Cell Melanoma Res. 2019 May;32(3):373-380. doi: 10.1111/pcmr.12748. Epub 2018 Nov 22.
Hermansky-Pudlak syndrome (HPS) is a rare recessive disorder characterized by oculocutaneous albinism (OCA) or ocular albinism (OA), bleeding tendency, and other symptoms due to multiple defects in tissue-specific lysosome-related organelles. Ten HPS subtypes have been characterized with mutations in HPS1 to HPS10, which encode the subunits of BLOC-1, -2, -3, and AP-3. Using next-generation sequencing (NGS), we have screened 100 hypopigmentation genes in OCA or OA patients and identified four HPS-1, one HPS-3, one HPS-4, one HPS-5, and three HPS-6. The HPS-4 case is the first report in the Chinese population. Among these 20 mutational alleles, 16 were previously unreported alleles (6 in HPS1, 1 in HPS3, 2 in HPS4, 2 in HPS5, and 5 in HPS6). BLOC-2 and BLOC-3 were destabilized due to the mutation of these HPS genes which are so far the only reported causative genes in Chinese HPS patients, in which HPS-1 and HPS-6 are the most common subtypes. The mutational spectrum of Chinese HPS is population specific.
Hermansky-Pudlak 综合征(HPS)是一种罕见的隐性疾病,其特征为眼皮肤白化病(OCA)或眼白化病(OA)、出血倾向和其他由于组织特异性溶酶体相关细胞器的多种缺陷引起的症状。已经确定了 10 种 HPS 亚型,其突变发生在 HPS1 到 HPS10 中,这些基因编码 BLOC-1、-2、-3 和 AP-3 的亚基。使用下一代测序(NGS),我们已经在 OCA 或 OA 患者中筛选了 100 个色素减退基因,并鉴定出了 4 种 HPS-1、1 种 HPS-3、1 种 HPS-4、1 种 HPS-5 和 3 种 HPS-6。HPS-4 病例是中国人群中的首例报告。在这 20 个突变等位基因中,有 16 个是以前未报道过的等位基因(HPS1 中 6 个,HPS3 中 1 个,HPS4 中 2 个,HPS5 中 2 个,HPS6 中 5 个)。由于这些 HPS 基因的突变,BLOC-2 和 BLOC-3 失稳,这些基因是迄今为止在中国 HPS 患者中唯一报道的致病基因,其中 HPS-1 和 HPS-6 是最常见的亚型。中国 HPS 的突变谱具有人群特异性。